Skip to main content
. 2016 Mar 31;14:83. doi: 10.1186/s12967-016-0836-6

Table 3.

Pharmacokinetic analysis of erlotinib in Schedule A patients

13 14 15 16 17 18
Erlotinib alone (day 6)
 AUC (μM) 23.45 29.68 45.44 46.19 13.87 50.14
 Cmax (μM) 2.17 1.83 2.73 2.97 0.86 3.42
 Tmax (h) 6 6 8 8 8 8
 t 1/2 (h) 7.1 25.7 18.1 15.1 15.4 9.4
Erlotinib (+rosuvastatin) (day 14)
 AUC (μM) off study 34.32 62.74 59.51 21.22 24.81
 Cmax (μM) off study 1.96 3.95 3.90 1.19 1.57
 Tmax (h) off study 8 6 10 10 8
 t1/2 (h) off study 24.3 14.5 12.8 12.8 13.3